The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 08, 2013
Filed:
Oct. 07, 2011
David J. Calderwood, Framingham, MA (US);
Noel S. Wilson, Kenosha, WI (US);
Philip Cox, Grayslake, IL (US);
Michael Z. Hoemann, Marlborough, MA (US);
Bruce Clapham, Lindenhurst, IL (US);
Anil Vasudevan, Union Grove, WI (US);
Clara I. Villamil, Glenview, IL (US);
Bin LI, Ashland, MA (US);
Gagandeep Somal, Framingham, MA (US);
Kelly D. Mullen, Charlton, MA (US);
David J. Calderwood, Framingham, MA (US);
Noel S. Wilson, Kenosha, WI (US);
Philip Cox, Grayslake, IL (US);
Michael Z. Hoemann, Marlborough, MA (US);
Bruce Clapham, Lindenhurst, IL (US);
Anil Vasudevan, Union Grove, WI (US);
Clara I. Villamil, Glenview, IL (US);
Bin Li, Ashland, MA (US);
Gagandeep Somal, Framingham, MA (US);
Kelly D. Mullen, Charlton, MA (US);
AbbVie Inc., North Chicago, IL (US);
Abstract
The present invention is directed to novel compounds of Formula (I) pharmaceutically acceptable salts, biologically active metabolites, pro-drugs, racemates, enantiomers, diastereomers, solvates and hydrates thereof wherein the variables are defined as herein. The compounds of Formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases and proliferative disorders and conditions, for example, cancers.